Eloxx Pharmaceuticals
@eloxx_pharma
Clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates to treat rare and ultra-rare premature stop codon diseases.
ID: 1281355319185215488
https://www.eloxxpharma.com/ 09-07-2020 22:31:38
74 Tweet
176 Followers
32 Following
$ELOX Eloxx Pharmaceuticals making progress on Phase 2 Clinical Study for ELX-02 Alport syndrome candidate tinyurl.com/2ehwjfq7 Eloxx Pharmaceuticals #ELOX
Join us on Monday, March 13th at 12:00 PM ET as we present at the Oppenheimer & Co. Inc. 33rd Annual Healthcare Conference. A live webcast and replay of the presentation will be available on our website: lnkd.in/g6cJBGTR
Alport syndrome is a #raredisease affecting 30k – 60k ppl and the cause of roughly 3% of children w/ chronic kidney disease. Eloxx is committed to advancing treatments for those with #AlportSyndrome due to nonsense mutations. Learn more from the National Kidney Foundation kidney.org/atoz/content/a…
Community support is important for anyone living with a rare disease. Patients & families impacted by #AlportSyndrome have the opportunity to come together in Oct @ the Alport Connect meeting hosted by the Alport Syndrome Foundation. Learn more: alportsyndrome.org/for-patients/a…